AI-Assisted Structured Guidance for Narrative Review Writing
Effect of Artificial Intelligence-Assisted Structured Guidance on the Quality of Narrative Literature Reviews Among Medical Postgraduate Students: A Randomized Controlled Educational Study
調査の概要
状態
詳細な説明
Generative artificial intelligence is increasingly used by medical students and postgraduate trainees for literature searching, summarization, outlining, and academic writing. However, free use of AI may be associated with inaccurate information, unsupported statements, fabricated references, and inadequate academic judgment. This study is designed to evaluate whether structured guidance can improve the quality and academic integrity of AI-assisted narrative review writing.
Participants will be medical postgraduate students enrolled in an academic writing course. After informed consent and baseline data collection, participants will be randomized in a 1:1 ratio to an AI-assisted structured guidance group or a free AI use group. Both groups will complete a narrative literature review of approximately 2,000 Chinese characters according to the same course requirements and may use AI tools under academic integrity requirements.
Participants in the AI-assisted structured guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six SANRA dimensions: explanation of the importance of the article, statement of aims or questions, description of the literature search, reference support for key statements, scientific reasoning, and appropriate presentation of data and content. The instructor will provide directional and methodological feedback but will not directly write or edit the students' text line by line. Participants in the free AI use group will complete the review according to the same course requirements without the structured guidance session.
After submission, all narrative reviews will be anonymized and assessed by independent outcome assessors blinded to group allocation. The primary outcome is the final SANRA total score. Secondary outcomes include SANRA item scores, multiple-source academic writing self-efficacy, and reference authenticity error rate.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Guangming Jin
- 電話番号：+86-13560035613
- メール：jinguangming@gzzoc.com
研究場所
-
-
Guangdong
-
Guangzhou、Guangdong、中国、510060
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Master's students enrolled in the Academic Standards and Thesis Writing course.
- Willing to participate in this study, able to understand the study procedures and randomization arrangement, and able to provide written informed consent.
- Able to complete literature searching, use AI tools, and complete online questionnaires.
Exclusion Criteria:
- Students who have confirmed withdrawal from the course, suspension of study, long-term leave, or other known objective reasons that prevent participation in subsequent major teaching activities and study procedures.
- Students who have participated in pilot testing, intervention material development, assessment training, or data processing related to this study.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：他の
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：AI-Assisted Structured Guidance Group
Participants in this group will complete a narrative literature review according to the same course requirements as the control group.
They may use AI tools under academic integrity requirements and will additionally receive one structured guidance session approximately two weeks before final submission.
|
A single structured guidance session delivered approximately two weeks before final submission.
The session is based on the six SANRA dimensions and provides directional and methodological feedback on narrative review writing and appropriate AI use, without direct writing or line-by-line editing of students' text.
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review.
Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
|
|
アクティブコンパレータ：Free AI Use Group
Participants in this group will complete a narrative literature review according to the same course requirements and may use AI tools under academic integrity requirements.
They will not receive the structured guidance session during the study period.
|
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review.
Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Final SANRA Total Score
時間枠：Week 2
|
The quality of the final narrative literature review will be assessed using the Scale for the Assessment of Narrative Review Articles (SANRA).
The SANRA total score ranges from 0 to 12, with higher scores indicating better quality of the narrative review.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
SANRA Item 1 Score: Importance of the Article
時間枠：Week 2
|
This outcome assesses SANRA item 1, which evaluates whether the importance of the narrative review article is adequately explained.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 2 Score: Aims or Questions
時間枠：Week 2
|
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 3 Score: Literature Search Description
時間枠：Week 2
|
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 4 Score: Referencing
時間枠：Week 2
|
At final submission of the narrative literature review; assessment completed within 4 weeks after final submission.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 5 Score: Scientific Reasoning
時間枠：Week 2
|
This outcome assesses SANRA item 5, which evaluates whether the scientific reasoning is based on appropriate evidence.
The item score ranges from 0 to 2, with higher scores indicating better scientific reasoning.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 6 Score: Data and Content Presentation
時間枠：Week 2
|
This outcome assesses SANRA item 6, which evaluates whether data and content are presented appropriately.
The item score ranges from 0 to 2, with higher scores indicating better presentation.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
Change From Baseline in Multiple-Source Academic Writing Self-Efficacy Score
時間枠：Baseline and Week 2
|
Multiple-source academic writing self-efficacy will be assessed using an adapted 8-item Multiple-Source Academic Writing Self-Efficacy Scale.
The change from baseline to final submission will be analyzed.
Higher scores indicate greater self-efficacy in integrating multiple sources for academic writing.
|
Baseline and Week 2
|
|
Reference Authenticity Error Rate
時間枠：Week 2
|
The proportion of references with authenticity errors will be calculated for each submitted narrative literature review.
References will be verified using available bibliographic information such as DOI, PMID, title, authors, PubMed, CrossRef, Web of Science, Google Scholar, journal websites, or publisher websites.
A higher error rate indicates poorer reference authenticity.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
協力者と研究者
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- IIT2026064
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。